(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Sets forth the rule for the consideration of H.R. 2427 (Pharmaceutical Market Access Act of 2003).
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in House
The House Committee on Rules reported an original measure, H. Rept. 108-231, by Mr. Sessions.
Placed on the House Calendar, Calendar No. 95.
The House Committee on Rules reported an original measure, H. Rept. 108-231, by Mr. Sessions.
Rule provides for consideration of H.R. 2427.
Considered as privileged matter. (consideration: CR 7/25/2003 H7531-7539, H7540-7541)
DEBATE - The House proceeded with one hour of debate on H. Res. 335.
DEBATE - The House continued with debate on H. Res. 335.
On ordering the previous question Agreed to by recorded vote: 417 - 10 (Roll no. 439).
Roll Call #439 (House)Passed/agreed to in House: On agreeing to the resolution Agreed to by voice vote.(text: CR 7/25/2003 H7531)
On agreeing to the resolution Agreed to by voice vote. (text: CR 7/25/2003 H7531)
Motion to reconsider laid on the table Agreed to without objection.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line